ENDOTHELIN-1 LEVELS IN ISCHEMIA, REPERFUSION, AND HEMORRHAGIC-SHOCK IN THE CANINE INFRARENAL AORTIC REVASCULARIZATION MODEL

被引:10
作者
EDWARDS, JD
DOVGAN, PS
ROWLEY, JM
AGRAWAL, DK
THORPE, PE
ADRIAN, TE
机构
[1] Creighton Vascular Center, Department of Surgery, Creighton University School of Medicine, Omaha, NE
[2] Creighton Vascular Center, Department of Radiology, Creighton University School of Medicine, Omaha, NE
[3] Creighton Vascular Center, Department of Biomedical Science, Creighton University School of Medicine, Omaha, NE
来源
EUROPEAN JOURNAL OF VASCULAR SURGERY | 1994年 / 8卷 / 06期
关键词
ENDOTHELIN-1; ISCHEMIA; REPERFUSION INJURY;
D O I
10.1016/S0950-821X(05)80654-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelin-1 (ET-1) is a potent vasoconstrictive polypeptide produced from vascular endothelial cells. The effects of ischaemia, reperfusion, and exsanguination on plasma ET-1 levels were studied and compared in the mongrel dog after infrarenal aortic cross clamping. Ischaemia produced a trend toward increased ET-1 serum levels (p < 0.07 with Bonferroni correction) that did not reach significance. Plasma ET-1 levels were significantly increased during reperfusion and even further elevations were found following exsanguination. We found a 2-3 fold increase in ET-1 levels following reperfusion (Initial 3.19 +/- 0.27 pg/ml vs. Reperfusion maximum 6.32 +/- 0.72 pg/ml, Bonferroni p < 0.01). Haemorrhagic shock was associated with a 3-4 fold increase in ET-1 levels (Initial 3.19 +/- 0.27 pg/ml vs. Exsanguination maximum 8.37 +/- 0.97 pg/ml Bonferroni p < 0.001). These data reveal that ET-1 is released during reperfusion and exsanguination and may mediate remote vascular events associated with infrarenal aortic cross clamping and acute blood loss.
引用
收藏
页码:729 / 734
页数:6
相关论文
共 44 条
[21]  
Zamora, O'Brien, Rutherford, Will, Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon, Lancet, 336, pp. 1144-1147, (1990)
[22]  
MacRae, Robinson, Graham, Reid, McCulloch, Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences, J Cereb Blood Flow Metab, 13, pp. 276-284, (1993)
[23]  
Vanhoutte, Auch-Schwelk, Boulanger, Jannesen, Katusic, Komori, Miller, Schini, Vidal, Does endothelin-1 mediate endothelium-dependent contractions during anoxia?, J Cardiovasc Pharm, 13, pp. S124-S128, (1989)
[24]  
Antonucci, Bertolissi, Calo, Plasma endothelin and renal function during infrarenal aortic crossclamping and nifedipine infusion, Lancet, 336, (1990)
[25]  
Chang, Wu, Wang, Hung, The role of endothelin-1 during ischemia-reperfusion injury, J Formos Med Assoc, 91, pp. 1182-1188, (1992)
[26]  
Nambi, Pullen, Jugus, Gellai, Rat kidney endothelin receptors in ischemia-induced acute renal failure, J Pharmacol Exp Ther, 264, pp. 345-348, (1993)
[27]  
Douglas, Vickery-Clark, Ohlstein, Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels, BR J Pharmacol, 108, pp. 418-421, (1993)
[28]  
Clozel, Loffler, Gloor, Relative preservation of the responsiveness to endothelin-1 during reperfusion following renal ischemia in the rat, J Cardiovasc Pharm, 17, pp. S313-S315, (1991)
[29]  
Maulik, Liu, Subramanian, Das, Release of endothelin during reperfusion of ischemic myocardium ET-1 release from reperfused heart, Am J Cardiovasc Pathol, 4, pp. 133-144, (1992)
[30]  
Tsuji, Sawamura, Watanabe, Takihara, Park, Azuma, Plasma endothelin levels during myocardial ischemia and reperfusion, Life Sci, 48, pp. 1745-1749, (1991)